{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:53:23Z","timestamp":1790016803460,"version":"4.0.1"},"reference-count":99,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Traditionally, platelets have been exclusively considered for their procoagulant and antifibrinolytic effects during normal activation of hemostasis. Effectively, activated platelets secrete coagulation factors, expose phosphatidylserine, and promote thrombin and fibrin production. In addition to procoagulant activities, platelets confer resistance of thrombi to fibrinolysis by inducing clot retraction of the fibrin network and release of huge amounts of plasminogen activator inhibitor-1, which is the major physiologic inhibitor of the fibrinolytic cascade. However, the discovery of multiple relations with the fibrinolytic system, also termed Plasminogen Activation System (PAS), has introduced new perspectives on the platelet role in fibrinolysis. Indeed, the activated membrane surface of platelets provides binding sites on which fibrinolytic enzymes can be activated. This review discusses the evidence of the profibrinolytic properties of platelets through the description of PAS components and related proteins that are contained in or bind to platelets. Our analyses of literature data lead to the conclusion that in the initial phase of the hemostatic process, antifibrinolytic effects prevail over profibrinolytic activity, but at later stages, platelets might enhance fibrinolysis through the engagement of PAS components. A better understanding of spatial and temporal characteristics of platelet-mediated fibrinolysis during normal hemostasis could improve therapeutic options for bleeding and thrombotic disorders.<\/jats:p>","DOI":"10.3390\/ijms23116065","type":"journal-article","created":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T08:50:51Z","timestamp":1653814251000},"page":"6065","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1925-9912","authenticated-orcid":false,"given":"Filomena","family":"Napolitano","sequence":"first","affiliation":[{"name":"Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80135 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-986X","authenticated-orcid":false,"given":"Nunzia","family":"Montuori","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80135 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,28]]},"reference":[{"key":"ref_1","unstructured":"LaPelusa, A., and Dave, H.D. (2022). Physiology, Hemostasis. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00001721-199210000-00012","article-title":"Plasminogen: A structural review","volume":"3","author":"Ponting","year":"1992","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.sbi.2013.10.006","article-title":"New insights into the structure and function of the plasminogen\/plasmin system","volume":"23","author":"Law","year":"2013","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1160\/TH04-12-0842","article-title":"Structure and function of the plasminogen\/plasmin system","volume":"93","author":"Castellino","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s000180050497","article-title":"The plasminogen activation system in tumor growth, invasion, and metastasis","volume":"57","author":"Andreasen","year":"2000","journal-title":"Cell Mol. Life Sci."},{"key":"ref_7","first-page":"642","article-title":"Structure and functions of plasminogen\/plasmin system","volume":"40","author":"Mukhametova","year":"2014","journal-title":"Bioorg. Khim."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2018.00024","article-title":"Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications","volume":"12","author":"Mahmood","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s12276-020-0397-x","article-title":"Therapeutics targeting the fibrinolytic system","volume":"52","author":"Lin","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00018-010-0566-5","article-title":"The plasmin\u2013antiplasmin system: Structural and functional aspects","volume":"68","author":"Schaller","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1016\/S0021-9258(18)37940-7","article-title":"One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity","volume":"263","author":"Petersen","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Li Santi, A., Napolitano, F., Montuori, N., and Ragno, P. (2021). The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084111"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Napolitano, F., Di Spigna, G., Vargas, M., Iacovazzo, C., Pinchera, B., Spalletti Cernia, D., Ricciardone, M., Covelli, B., Servillo, G., and Gentile, I. (2021). Soluble Urokinase Receptor as a Promising Marker for Early Prediction of Outcome in COVID-19 Hospitalized Patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10214914"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5482\/HAMO-14-10-0050","article-title":"What drives \u201cfibrinolysis\u201d?","volume":"35","author":"Medcalf","year":"2015","journal-title":"Hamostaseologie"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1432-1033.1988.tb14162.x","article-title":"Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2","volume":"175","author":"Thorsen","year":"1988","journal-title":"Eur. J. Biochem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sillen, M., and Declerck, P.J. (2021). Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073670"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1524-475X.2003.11402.x","article-title":"Plasminogen activator\/plasmin system: A major player in wound healing?","volume":"11","author":"Li","year":"2003","journal-title":"Wound Repair Regen"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e20191865","DOI":"10.1084\/jem.20191865","article-title":"A critical role for plasminogen in inflammation","volume":"217","author":"Baker","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1160\/TH05-01-0054","article-title":"Plasminogen activation and cancer","volume":"93","author":"Behrendt","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_20","first-page":"34","article-title":"The Urokinase\/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors","volume":"15","author":"Rossi","year":"2016","journal-title":"Transl. Med. UniSa"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Napolitano, F., and Montuori, N. (2021). The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030518"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10555-017-9677-x","article-title":"Normal platelet function","volume":"36","author":"Holinstat","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1538-7836.2007.02690.x","article-title":"Proteomic analysis of platelet alpha-granules using mass spectrometry","volume":"5","author":"Maynard","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MOH.0b013e3283632e6b","article-title":"Advances in platelet granule biology","volume":"20","author":"Koseoglu","year":"2013","journal-title":"Curr. Opin. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet alpha-granules: Basic biology and clinical correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09537100120068170","article-title":"The platelet release reaction: Granules\u2019 constituents, secretion and functions","volume":"12","author":"Rendu","year":"2001","journal-title":"Platelets"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: From haemostasis to wound healing and beyond","volume":"29","author":"Golebiewska","year":"2015","journal-title":"Blood Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/rth2.12107","article-title":"Integrating platelet and coagulation activation in fibrin clot formation","volume":"2","author":"Swieringa","year":"2018","journal-title":"Res. Pr. Thromb. Haemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fmed.2018.00317","article-title":"The Platelet Response to Tissue Injury","volume":"5","author":"Eisinger","year":"2018","journal-title":"Front. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1182\/blood-2010-05-283838","article-title":"Deciphering the human platelet sheddome","volume":"117","author":"Fong","year":"2011","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MOH.0000000000000070","article-title":"Shaping the platelet response to vascular injury","volume":"21","author":"Stalker","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1160\/TH09-05-0289","article-title":"Platelet response heterogeneity in thrombus formation","volume":"102","author":"Munnix","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood.V79.6.1420.1420","article-title":"Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction","volume":"79","author":"Kunitada","year":"1992","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0076-6879(93)23045-O","article-title":"Human alpha 2-plasmin inhibitor","volume":"223","author":"Aoki","year":"1993","journal-title":"Methods Enzym."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0036-1597283","article-title":"Platelet-Mediated Modulation of Fibrinolysis","volume":"43","author":"Whyte","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/bloodadvances.2020002923","article-title":"Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system","volume":"4","author":"Suzuki","year":"2020","journal-title":"Blood Adv."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gresele, P., Kleiman, N., Lopez, J., and Page, C. (2017). Platelets and Fibrinolysis. Platelets in Thrombotic and Non-Thrombotic Disorders, Springer.","DOI":"10.1007\/978-3-319-47462-5"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1182\/blood-2003-08-2804","article-title":"Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions","volume":"103","author":"Coppinger","year":"2004","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2008-08-172338","article-title":"Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation","volume":"113","author":"Veljkovic","year":"2009","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1016\/S0021-9258(18)89264-X","article-title":"Binding and activation of plasminogen on the platelet surface","volume":"260","author":"Miles","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11928","DOI":"10.1016\/S0021-9258(18)37875-X","article-title":"The cell-binding domains of plasminogen and their function in plasma","volume":"263","author":"Miles","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood.V72.5.1530.1530","article-title":"Plasminogen interactions with platelets in plasma","volume":"5","author":"Adelman","year":"1988","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-0038-1642692","article-title":"Platelets and plasminogen activation","volume":"74","author":"Loscalzo","year":"1995","journal-title":"Thromb Haemost"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1538-7836.2010.03813.x","article-title":"Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: A mechanism for stimulation of fibrinolysis by platelets","volume":"8","author":"Baeten","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood-2009-06-228817","article-title":"Fibrinolytic cross-talk: A new mechanism for plasmin formation","volume":"115","author":"Dejouvencel","year":"2010","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2014-09-599480","article-title":"Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow","volume":"125","author":"Whyte","year":"2015","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood.2020007263","article-title":"Exposure of plasminogen and a novel plasminogen receptor, Plg-RKT, on activated human and murine platelets","volume":"137","author":"Whyte","year":"2021","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1055\/s-0038-1660505","article-title":"Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review","volume":"2","author":"Remijn","year":"2018","journal-title":"TH Open"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1172\/JCI107345","article-title":"Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis","volume":"52","author":"Niewiarowski","year":"1973","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0006-2952(00)00279-3","article-title":"On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP","volume":"59","author":"Uchida","year":"2000","journal-title":"Biochem. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"18434","DOI":"10.1074\/jbc.M401431200","article-title":"Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4","volume":"279","author":"Quinton","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.CIR.96.2.569","article-title":"Aprotinin inhibits plasmin-induced platelet activation during cardiopulmonary bypass","volume":"96","author":"Shigeta","year":"1997","journal-title":"Circulation"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Pielsticker, C., Brodde, M.F., Raum, L., Jurk, K., and Kehrel, B.E. (2020). Plasmin-Induced Activation of Human Platelets Is Modulated by Thrombospondin-1, Bona Fide Misfolded Proteins and Thiol Isomerases. Int J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228851"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/09537109609023572","article-title":"The effect of plasmin on platelet function","volume":"7","author":"Blockmans","year":"1996","journal-title":"Platelets"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI111720","article-title":"Plasmin inhibition of platelet function and of arachidonic acid metabolism","volume":"75","author":"Schafer","year":"1985","journal-title":"J. Clin. Invest."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.CIR.85.3.935","article-title":"In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis","volume":"85","author":"Gouin","year":"1992","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"15869","DOI":"10.1016\/S0021-9258(18)71558-5","article-title":"Characterization of the binding of human tissue-type plasminogen activator to platelets","volume":"264","author":"Vaughan","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00737224","article-title":"Tissue-plasminogen activator RNA detected in megakaryocytes by in situ hybridization and biotinylated probe","volume":"95","author":"Nelles","year":"1990","journal-title":"Histochemistry"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0038-1642466","article-title":"Demonstration of a functionally active tPA-like plasminogen activator in human platelets","volume":"71","author":"Wang","year":"1994","journal-title":"Thromb. Haemost."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.1073\/pnas.89.17.8087","article-title":"S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme","volume":"89","author":"Stamler","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/hh0402.105095","article-title":"A structural and dynamic investigation of the facilitating effect of glycoprotein IIb\/IIIa inhibitors in dissolving platelet-rich clots","volume":"90","author":"Collet","year":"2002","journal-title":"Circ. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/SHK.0000000000000245","article-title":"Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: Evolving concepts of the spectrum of fibrinolysis in response to severe injury","volume":"43","author":"Moore","year":"2015","journal-title":"Shock"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MBC.0b013e3282f41e3e","article-title":"Quebec platelet disorder: Features, pathogenesis and treatment","volume":"19","author":"Diamandis","year":"2008","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-5793(93)80537-5","article-title":"Pro-urokinase and prekallikrein are both associated with platelets. Implications for the intrinsic pathway of fibrinolysis and for therapeutic thrombolysis","volume":"318","author":"Gurewich","year":"1993","journal-title":"FEBS Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-0038-1642441","article-title":"Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: A mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis","volume":"71","author":"Loza","year":"1994","journal-title":"Thromb. Haemost."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1021\/bi00142a021","article-title":"Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK","volume":"31","author":"Liu","year":"1992","journal-title":"Biochemistry"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"18554","DOI":"10.1016\/S0021-9258(17)46663-4","article-title":"Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis","volume":"268","author":"Fleury","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1182\/blood.V67.5.1215.1215","article-title":"Pro-urokinase: A study of its stability in plasma and of a mechanism for its selective fibrinolytic effect","volume":"67","author":"Pannell","year":"1986","journal-title":"Blood"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V98.2.257","article-title":"Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator","volume":"98","author":"Kahr","year":"2001","journal-title":"Blood"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Hayward, C.P.M., Liang, M., Tasneem, S., Soomro, A., Waye, J.S., Paterson, A.D., Rivard, G.E., and Wilson, M.D. (2017). The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173991"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1055\/s-0037-1613246","article-title":"Platelet associated u-PA up-regulates u-PA synthesis by endothelial cells","volume":"88","author":"Pannell","year":"2002","journal-title":"Thromb. Haemost."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1538-7836.2006.01878.x","article-title":"Generation of platelet angiostatin mediated by urokinase plasminogen activator: Effects on angiogenesis","volume":"4","author":"Jurasz","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1161\/01.CIR.99.25.3315","article-title":"Urokinase receptor (uPAR, CD87) is a platelet receptor important for kinetics and TNF-induced endothelial adhesion in mice","volume":"99","author":"Piguet","year":"1999","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.exphem.2008.06.016","article-title":"Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients","volume":"36","author":"Sloand","year":"2008","journal-title":"Exp. Hematol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.4049\/jimmunol.1402819","article-title":"Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts","volume":"194","author":"Rossi","year":"2015","journal-title":"J. Immunol"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fimmu.2018.00574","article-title":"N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor","volume":"9","author":"Napolitano","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.exphem.2004.09.010","article-title":"Human platelets exhibit chemotaxis using functional N-formyl peptide receptors","volume":"33","author":"Czapiga","year":"2005","journal-title":"Exp. Hematol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/bloodadvances.2018021758","article-title":"The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation","volume":"2","author":"Salamah","year":"2018","journal-title":"Blood Adv."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood-2004-04-1439","article-title":"Platelets synthesize large amounts of active plasminogen activator inhibitor 1","volume":"104","author":"Brogren","year":"2004","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/107602960501100209","article-title":"The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis","volume":"11","author":"Birdane","year":"2005","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Brogren, H., Wallmark, K., Deinum, J., Karlsson, L., and Jern, S. (2011). Platelets retain high levels of active plasminogen activator inhibitor 1. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026762"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.thromres.2008.04.008","article-title":"Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin","volume":"122","author":"Brogren","year":"2008","journal-title":"Thromb. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood.V81.5.1290.1290","article-title":"Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: Light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus","volume":"81","author":"Braaten","year":"1993","journal-title":"Blood"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0049-3848(93)90198-W","article-title":"The potential role of platelet PAl-1 in t-PA mediated clot lysis of platelet rich plasma","volume":"71","author":"Serizawa","year":"1993","journal-title":"Thromb. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0038-1642655","article-title":"Plasminogen activator inhibitor 1 (PAI-1) in plasma: Its role in thrombotic disease","volume":"74","author":"Wiman","year":"1995","journal-title":"Thromb. Haemost."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1074\/jbc.M109675200","article-title":"Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface","volume":"277","author":"Podor","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.99.23.3050","article-title":"Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance","volume":"99","author":"Zhu","year":"1999","journal-title":"Circulation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0038-1650232","article-title":"Proteins of the fibrinolytic system in human thrombi","volume":"75","author":"Robbie","year":"1996","journal-title":"Thromb. Haemost."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/SHK.0000000000001089","article-title":"Thrombin Provokes Degranulation of Platelet \u03b1-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1)","volume":"50","author":"Huebner","year":"2018","journal-title":"Shock"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3324\/haematol.2019.217463","article-title":"Platelet HIF-2\u03b1 promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release","volume":"104","author":"Chaurasia","year":"2019","journal-title":"Haematologica"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1111\/jcmm.12617","article-title":"Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells","volume":"19","author":"Alfano","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diacare.18.8.1150","article-title":"Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes","volume":"18","author":"Jokl","year":"1995","journal-title":"Diabetes Care"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"36687","DOI":"10.1038\/srep36687","article-title":"Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets","volume":"6","author":"Luo","year":"2016","journal-title":"Sci Rep."},{"key":"ref_94","first-page":"38","article-title":"Fibrinolytic imbalance in essential thrombocythemia: Role of platelets","volume":"23","author":"Bazzan","year":"1993","journal-title":"Haemostasis"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/09537104.2018.1535702","article-title":"SerpinB2 deficiency in mice reduces bleeding times via dysregulated platelet activation","volume":"30","author":"Schroder","year":"2019","journal-title":"Platelets"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0076-6879(89)69069-6","article-title":"Platelet alpha 2-antiplasmin","volume":"169","author":"Plow","year":"1989","journal-title":"Methods Enzymol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1182\/blood-2014-06-583070","article-title":"Functional factor XIII-A is exposed on the stimulated platelet surface","volume":"124","author":"Mitchell","year":"2014","journal-title":"Blood"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1025096609558","article-title":"Lack of alpha 2-antiplasmin enhances ADP induced platelet micro-aggregation through the presence of excess active plasmin in mice","volume":"14","author":"Takei","year":"2002","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Brzoska, T., Tanaka-Murakami, A., Suzuki, Y., Sano, H., Kanayama, N., and Urano, T. (2015). Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site-dependent plasminogen accumulation in microthrombi. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122196"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/6065\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:20:28Z","timestamp":1760138428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/6065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,28]]},"references-count":99,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijms23116065"],"URL":"https:\/\/doi.org\/10.3390\/ijms23116065","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,28]]}}}